Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet

The probiotic Lactobacillus gasseri SBT2055 (LG2055) has anti-obesity effects. Obesity is closely correlated with inflammation in adipose tissue, and maintaining adipose tissue in a less-inflamed state requires intestinal integrity or a barrier function to protect the intestine from the disruption t...

Full description

Bibliographic Details
Main Authors: Michio Kawano, Masaya Miyoshi, Akihiro Ogawa, Fumihiko Sakai, Yukio Kadooka
Format: Article
Language:English
Published: Cambridge University Press 2016-01-01
Series:Journal of Nutritional Science
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2048679016000124/type/journal_article
_version_ 1811155935792463872
author Michio Kawano
Masaya Miyoshi
Akihiro Ogawa
Fumihiko Sakai
Yukio Kadooka
author_facet Michio Kawano
Masaya Miyoshi
Akihiro Ogawa
Fumihiko Sakai
Yukio Kadooka
author_sort Michio Kawano
collection DOAJ
description The probiotic Lactobacillus gasseri SBT2055 (LG2055) has anti-obesity effects. Obesity is closely correlated with inflammation in adipose tissue, and maintaining adipose tissue in a less-inflamed state requires intestinal integrity or a barrier function to protect the intestine from the disruption that can be caused by a high-fat diet (HFD). Here, we examined the anti-inflammatory and intestinal barrier-protecting effects of LG2055 in C57BL/6 mice fed a normal-fat diet (NFD), HFD, or the HFD containing LG2055 (HFD-LG) for 21 weeks. HFD-LG intake significantly prevented HFD-induced increases in body weight, visceral fat mass, and the ratio of inflammatory-type macrophages to anti-inflammatory ones in adipose tissue. Mice fed the HFD showed higher intestinal permeability to a fluorescent dextran administered by oral administration and an elevated concentration of antibodies specific to lipopolysaccharides (LPS) in the blood compared with those fed the NFD, suggesting an increased penetration of the gut contents into the systemic circulation. These elevations of intestinal permeability and anti-LPS antibody levels were significantly suppressed in mice fed the HFD-LG. Moreover, treatment with LG2055 cells suppressed an increase in the cytokine-induced permeability of Caco-2 cell monolayers. These results suggest that LG2055 improves the intestinal integrity, reducing the entry of inflammatory substances like LPS from the intestine, which may lead to decreased inflammation in adipose tissue.
first_indexed 2024-04-10T04:43:16Z
format Article
id doaj.art-b3b785959b5d492898f92d87e44c999e
institution Directory Open Access Journal
issn 2048-6790
language English
last_indexed 2024-04-10T04:43:16Z
publishDate 2016-01-01
publisher Cambridge University Press
record_format Article
series Journal of Nutritional Science
spelling doaj.art-b3b785959b5d492898f92d87e44c999e2023-03-09T12:38:49ZengCambridge University PressJournal of Nutritional Science2048-67902016-01-01510.1017/jns.2016.12Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat dietMichio Kawano0Masaya Miyoshi1Akihiro Ogawa2Fumihiko Sakai3Yukio Kadooka4Milk Science Research Institute, Megmilk Snow Brand Co. Ltd, 1-1-2 Minamidai, Kawagoe, Saitama, JapanMilk Science Research Institute, Megmilk Snow Brand Co. Ltd, 1-1-2 Minamidai, Kawagoe, Saitama, JapanMilk Science Research Institute, Megmilk Snow Brand Co. Ltd, 1-1-2 Minamidai, Kawagoe, Saitama, JapanMilk Science Research Institute, Megmilk Snow Brand Co. Ltd, 1-1-2 Minamidai, Kawagoe, Saitama, JapanMilk Science Research Institute, Megmilk Snow Brand Co. Ltd, 1-1-2 Minamidai, Kawagoe, Saitama, JapanThe probiotic Lactobacillus gasseri SBT2055 (LG2055) has anti-obesity effects. Obesity is closely correlated with inflammation in adipose tissue, and maintaining adipose tissue in a less-inflamed state requires intestinal integrity or a barrier function to protect the intestine from the disruption that can be caused by a high-fat diet (HFD). Here, we examined the anti-inflammatory and intestinal barrier-protecting effects of LG2055 in C57BL/6 mice fed a normal-fat diet (NFD), HFD, or the HFD containing LG2055 (HFD-LG) for 21 weeks. HFD-LG intake significantly prevented HFD-induced increases in body weight, visceral fat mass, and the ratio of inflammatory-type macrophages to anti-inflammatory ones in adipose tissue. Mice fed the HFD showed higher intestinal permeability to a fluorescent dextran administered by oral administration and an elevated concentration of antibodies specific to lipopolysaccharides (LPS) in the blood compared with those fed the NFD, suggesting an increased penetration of the gut contents into the systemic circulation. These elevations of intestinal permeability and anti-LPS antibody levels were significantly suppressed in mice fed the HFD-LG. Moreover, treatment with LG2055 cells suppressed an increase in the cytokine-induced permeability of Caco-2 cell monolayers. These results suggest that LG2055 improves the intestinal integrity, reducing the entry of inflammatory substances like LPS from the intestine, which may lead to decreased inflammation in adipose tissue.https://www.cambridge.org/core/product/identifier/S2048679016000124/type/journal_article Lactobacillus gasseri SBT2055Intestinal barrier functionAnti-obesity effectsAnti-inflammation effectsDiet-induced obesity
spellingShingle Michio Kawano
Masaya Miyoshi
Akihiro Ogawa
Fumihiko Sakai
Yukio Kadooka
Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet
Journal of Nutritional Science
Lactobacillus gasseri SBT2055
Intestinal barrier function
Anti-obesity effects
Anti-inflammation effects
Diet-induced obesity
title Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet
title_full Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet
title_fullStr Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet
title_full_unstemmed Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet
title_short Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet
title_sort lactobacillus gasseri sbt2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high fat diet
topic Lactobacillus gasseri SBT2055
Intestinal barrier function
Anti-obesity effects
Anti-inflammation effects
Diet-induced obesity
url https://www.cambridge.org/core/product/identifier/S2048679016000124/type/journal_article
work_keys_str_mv AT michiokawano lactobacillusgasserisbt2055inhibitsadiposetissueinflammationandintestinalpermeabilityinmicefedahighfatdiet
AT masayamiyoshi lactobacillusgasserisbt2055inhibitsadiposetissueinflammationandintestinalpermeabilityinmicefedahighfatdiet
AT akihiroogawa lactobacillusgasserisbt2055inhibitsadiposetissueinflammationandintestinalpermeabilityinmicefedahighfatdiet
AT fumihikosakai lactobacillusgasserisbt2055inhibitsadiposetissueinflammationandintestinalpermeabilityinmicefedahighfatdiet
AT yukiokadooka lactobacillusgasserisbt2055inhibitsadiposetissueinflammationandintestinalpermeabilityinmicefedahighfatdiet